Limited Nicotine Sales in France Due to Clinical Trials

The French government has temporarily limited sales of nicotine replacement products after French researchers announced a clinical trial to determine if nicotine can help prevent coronavirus infection, or treat COVID-19 complications. The temporary restrictions do not affect consumer products like nicotine vapes or tobacco products.

The government said the restriction are intended to prevent “excessive consumption” inspired by the announcement of the studies showing nicotine’s promise as a COVID-preventive medication, and to guarantee a “continuous and appropriate supply to people requiring medical support to stop smoking.”

Continue Reading On: Vaping360.com